The Ministry of Health confirmed four cases of cholera in Blue Nile state. It said in a statement issued yesterday that the National Laboratory for Public Health notified the ministry of the presence of cholera bacteria in four of the six samples it received from infected patients in Blue Nile state. Cases of typhoid have been found as well.

So far, the Health Ministry has referred to cases that many believe to be cholera as ‘acute watery"...

Khartoum – Federal Ministry of Health on Tuesday announced that four cholera infection cases have been reported in Blue Nile state, affirming that the number of cases of watery diarrhea most possibly caused by cholera, has risen to 40 in state hospitals three of them died.
The Ministry said in a statement that Sudan’s Health Minister, Akram Ali Al-Tom, has officially reported the cases to the World Health Organization (WHO).
It also said two teams from the Federal Health Ministry and the WHO have arrived"...

Royal Philips and the largest African health organisation Amref Health Africa signed a Memorandum of Understanding (MoU) to extend their joint mission to sustainably transform primary healthcare towards achieving universal health coverage (UHC), in Africa.

The collaboration, which started in 2013, will build on its strategic objective to improve access to community and primary care for 10 million people in underserved areas in Africa, as it enters"...

Polycystic Ovarian Syndrome (PCOS) is among the most common causes of infertility among women in the UAE. In order to address this issue, during the ‘PCOS Awareness Month’ in September, Fakih IVF is looking to reach out to all women by providing them with services that would educate them more on the subject.

PCOS is the most common endocrinopathy (hormonal disturbance) affecting reproductive aged women, with a prevalence of between 8"...

Sudan’s National Medicines and Poisons Board has participated in the Medicines Quality Test of the border areas targeted by the Intergovernmental Authority on Development (IGAD) and the analyses conducted proved that the Sudanese medicines conform to the specifications; which means that there are adequate conditions to ensure the quality of the drugs through its various distribution channels even in the border areas. IGAD has called on countries such as Sudan, South Sudan, Ethiopia, Uganda, Kenya, Somalia and Djibouti"...

Samsung Bioepis Co., Ltd. today announced its expansion into the Brazilian biopharmaceutical market. The first product available in the country is BRENZYS™ (etanercept), a biosimilar referencing ENBREL®.i BRENZYS™ was approved by Agência Nacional de Vigilância Sanitária (ANVISA), the country’s health regulatory agency, in December 2017 for the treatment of rheumatoid arthritis, ankylosing spondylitis, plaque psoriasis, psoriatic arthritis, and non-radiographic axial spondyloarthritis.

The Doctors Committee in Blue Nile State warned that a cholera epidemic threatens the country. Spokeswoman Dr Shiraz Ahmed called on the Ministry of Health to intervene urgently and take preventive measures to prevent an outbreak of the epidemic.

The Doctors Committee in Blue Nile State reported that more than 30 patients suffered from “acute watery diarrhoea” in the state by Friday. Three of them died and 15 were discharged.

Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces that it has initiated investigational new drug (IND)-enabling studies for ALS-4, a small drug molecule candidate indicated for the treatment of infections caused by Staphylococcus aureus (or “S. aureus”) including methicillin-resistant Staphylococcus aureus (MRSA, i.e., one of the commonly known “super-bugs”)"...

Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces the development of two preclinical drug candidates which target obesity and neuroblastoma, respectively.

About CLS-1: Treatment of obesity via modulation of chemical signaling relating to gut microbiota

Under"...

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced positive results from two pivotal Phase 3 clinical studies (ASPIRE I & II) to evaluate the efficacy and safety of esketamine nasal spray in addition to comprehensive standard of care (SOC) in adult patients with major depressive disorder who have active suicidal ideation with intent. These studies were presented at the 32nd European College of Neuropsychopharmacology (ECNP), taking place September 7–10 in Copenhagen.

The"...